• About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us
Assamese |   Bengali |  
Thursday, April 22, 2021
NORTHEAST NOW
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
NORTHEAST NOW
Assamese
Home Health

Serum Institute of India to resume clinical trials of Oxford COVID-19 vaccine

NE NOW NEWS by NE NOW NEWS
September 16, 2020 1:12 pm
COVID-19 vaccine

Representational image. Image credit: Times Now

Share on FacebookShare on Twitter

The Serum Institute of India (SII) on Tuesday received permission from Drugs Controller General of India (DCGI) V G Somani to resume clinical trial of the Oxford COVID-19 vaccine in the country.

Although the DGCI had revoked its earlier order of suspending any new recruitment for phase two and three trial, it has set certain conditions that had been asked to be strictly followed by the pharmaceutical company.

During the trial phase, the firm has been asked to follow conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events at the time of follow-up of the study.

ALSO READ Serum Institute pauses COVID-19 vaccine trials in India

SII has also been asked to submit to the DCGI’s office details of medication used in accordance with the protocol for the management of adverse events.

The firm, which has partnered with UK based company AstraZeneca for manufacturing the vaccine candidate for COVID-19, had recently paused the clinical trials of the vaccine in the country after receiving instructions from the DGCI.

Due to the report of unexplained illness in a study participant in the UK, AstraZeneca has halted global trials of its experimental coronavirus vaccine following which even the DGCI had directed SII to halt the clinical trial phase of the vaccine in India.

On Saturday, AstraZeneca and the University of Oxford said clinical trials for their coronavirus vaccine have resumed in the UK after the Medicines Health Regulatory Authority’s (MHRA) confirmed that the trials were safe.

The DGCI has also asked SII to submit approvals from Data Safety Monitoring Boards (DSMB) of India and the UK to resume the COVID-19 vaccine trial.

On Tuesday, the SII had submitted the recommendations of the DMSB of India and the UK and requested for permission to restart enrolment in the clinical trial.

NORTHEAST NOW

Northeast Now is a multi-app based hyper-regional bilingual news portal. Led by a group of professionals, the digital news platform covers every inch of the eight states of northeast India and the five neighbouring countries. It is the first of its kind new media initiative in the northeast, and is based in Guwahati. As the political dynamics in the northeast is intricate and fluid, Northeast Now is always politically neutral.

 
Our Properties
 
  • NORTHEAST NOW ASSAMESE
  • NORTHEAST JOBS
  • NORTHEAST TENDERS
  • INNFINITY
  • About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd

No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd